A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre.
about
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study.Comparability of biosimilar filgrastim with originator filgrastim: protein characterization, pharmacodynamics, and pharmacokinetics.Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric studyEfficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study.Clinical safety of biosimilar recombinant human granulocyte colony-stimulating factors.Clinical experience with Zarzio® in Europe: what have we learned?Biosimilars for the management of rheumatoid arthritis: economic considerations.Efficacy and safety of biosimilar filgrastim in primary and secondary prevention of febrile neutropeniaComparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma.Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study).Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.
P2860
Q31085610-4609B8BF-564F-4ED3-8E88-F8767884EC37Q35547653-3B75399F-4135-4495-86B5-E56BCCC3391EQ36723952-E768C9E8-0EF7-4756-BD11-C42C9D5BF340Q37616966-D37C726C-26D0-4412-825A-4C5AAD29FF39Q38082542-1822A449-200D-4913-A165-DF783113A261Q38125609-CF87C4E7-C452-4743-B406-8122893AAA7DQ38591281-6C96C154-9171-499E-9CFD-10E873627F07Q38626569-E0E9970D-525F-4B4C-A631-4BB130506D40Q38707629-B625125D-1B93-4747-BE15-A6C72A22CAD9Q40141879-9C5FBB0D-EDCC-4548-97B3-D6B24A454CF0Q50042993-73ACC467-3851-4576-89E6-1C8BD8C9A2DB
P2860
A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A non-interventional study of ...... n a community oncology centre.
@ast
A non-interventional study of ...... n a community oncology centre.
@en
type
label
A non-interventional study of ...... n a community oncology centre.
@ast
A non-interventional study of ...... n a community oncology centre.
@en
prefLabel
A non-interventional study of ...... n a community oncology centre.
@ast
A non-interventional study of ...... n a community oncology centre.
@en
P2860
P356
P1476
A non-interventional study of ...... n a community oncology centre.
@en
P2093
Karl Verpoort
Thomas M Möhler
P2860
P304
P356
10.1177/1758834012461330
P577
2012-11-01T00:00:00Z